IR contact

Dr. Mathias Svahn, CEO

Leo Groenewegen, CFO

Phone: +46 (0)8-735 5595





Please contact CEO Dr. Mathias Svahn for an investor pack and other information.

Financial calendar 2018

Q1 report

31 January 2018

Q3 report

31 July 2018

Q2 report

30 April 2018


October 31th 2018

Financial calendar 2017

Interim Report

31 July 2017

Year-End Report

31 October 2017

Annual Report

14 November 2017

Annual General Meeting

Conducted December 5th 2017

Share information


NextCell has to date paid no dividends to its shareholders. The company is in a development phase, and any surplus is primarily planned for reinvestment in the company’s development. There is a risk that future cash flows will not exceed the company’s capital requirements and that future AGMs will not decide on future dividends.


Shares in NextCell Pharma AB are traded on Aktietorget as per July 2017.

List of 5 largest shareholders as per 2018-03-31

Owners   Ownership (%)
Diamyd Medical AB*  1 173 723 13,8
Avanza Pension  972 170 11,43
Anders Essen-Möller**  546 898 6,43
Bertil Lindkvist  444 833 5,23
Göran Ofsen  380 192 4,47
Other owners  4 987 581*** 58,64***
Total 8 505 425 100.00

* NextCell’s Board Chairman Anders Essen-Möller owns 16.8% of the shares and 40.1% of the votes in Diamyd Medical AB.

** Anders Essen-Möller is the Board Chairman of NextCell.

*** Numbers are close approximations and can deviate slightly form reality

Share price

The current share price is available on Aktietorget.

Corporate governance


There is no information to enter under this point


Bo Åsell

Öhrlings PricewaterhouseCoopers AB (PwC)
Torsgatan 21, 113 97 Stockholm

Bo Åsell is an Authorized Public Accountant and a member of FAR, the institute for the accountancy profession in Sweden.

Nomination Committee

No information available

Articles of Association

Incentive programmes

NextCell Pharma AB currently has no active incentive programmes.


 Registration form

NextCell Pharma - Anmälningssedel


Instruction for subscription registration

Instructions are included in the subscription form. 


NextCell Pharma AB is listed on the AktieTorget stock exchange since July 2017.

Link to aktietorget

Link to NextCell's IR page on Aktietorget